ClinicalTrials.gg
Status unknownNCT02752399Updated Apr 27, 2016

Six Minutes Walk Test and Shuttle Walk Test in Eisenmenger Syndrome

An observational study in Eisenmenger Complex, Pulmonary Hypertension and Congenital Heart Defects, sponsored by Federal University of São Paulo. Status unknown at 1 site in Brazil. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2016-04-27.

Sponsored by Federal University of São Paulo · Observational

The sponsor has not verified this record recently (last verified Apr 2016), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
60
Ages
16 Years and older
Sex
All
01

Study summary

The purpose of this study is to verify the applicability Six minutes walk test and Shuttle walk test in assessing functional capacity in patients with Eisenmenger Syndrome. Patients will undergo three functional tests, being the six-minute walk test, shuttle walk test and cardiopulmonary exercise test on a cycle ergometer, associated with evaluation of metabolic and ventilatory variables and cardiac monitoring throughout the test.

Read the detailed description

It has seen an increasing number of individuals with congenital heart diseases mainly due to the development of new diagnostic techniques, assessment and treatment, thereby contributing to longer survival. These individuals that survive to adulthood, many sometimes develop other secondary problems to the underlying pathology, one of Pulmonary Arterial Hypertension. The Syndrome Eisenmenger is the most advanced form of pulmonary hypertension secondary to congenital heart defects. It is known that patients with pulmonary hypertension secondary congenital heart disease have marked functional limitation and high risk of death. Among the various forms of assess exercise capacity, Walk Test Six Minutes (6MWT), Shuttle walking test and Cardiopulmonary Exercise Test are among the most applicable. Little has been studied about the patients with pulmonary hypertension secondary to congenital heart disease and Eisenmenger Syndrome. The characterization of this profile of patients against the effort becomes necessary and useful in determining strategies and identification of factors that may be limited to functional capacity and quality of life. Objectives: To verify the applicability Six minutes walk test and Shuttle walk test in assessing functional capacity in patients with Eisenmenger Syndrome. Methods: Cross-sectional study with patients diagnosed with Eisenmenger Syndrome, of both sexes, without changing pace or lower limbs, who have performed echocardiography in the last 6 months and clinical stability. Patients will undergo three functional tests, being the six-minute walk test, shuttle walk test and cardiopulmonary exercise test on a cycle ergometer, associated with evaluation of metabolic and ventilatory variables and cardiac monitoring throughout the test. Also will be held assess respiratory endurance and strength, peripheral muscle strength and manual pinch, Heart rate variability, inflammatory mediators and blood lactate, besides questionnaires about quality of life, quality of sleep and daytime drowsiness.

02

Conditions studied

  • Eisenmenger Complex
  • Pulmonary Hypertension
  • Congenital Heart Defects
03

In context

Eisenmenger Complex

23 studies on the registry are indexed under Eisenmenger Complex; 5 are open to participants now.

Browse Eisenmenger Complex studies →

Lead sponsor

Federal University of São Paulo is the lead sponsor of 439 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with eisenmenger syndrome that do ambulatory monitoring of congenital heart of Federal University of São Paulo.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Eisenmenger syndrome
  • To understand the realization of tests
  • That do ambulatory monitoring of congenital heart of Federal University of São Paulo..

Exclusion criteria

Exclusion Criteria:

  • Donw Syndrome
  • Changing pace or lower limbs
  • Neuromuscular disease
  • Pulmonary Obstructive disease
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
60 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Six minute walk test to measure functional capacity in eisenmenger syndrome

    Six minute walk test will be done with metabolic and ventilatory monitoring and Compared to the cardiopulmonary exercise testing variables , seeing your similarity and if this first test is applicable to measurement functional capacity in Eisenmenger syndrome

    Time frame: One day

  2. Shuttle walk test to measure functional capacity in Eisenmenger syndrome

    Shuttle walk test will be done with metabolic and ventilatory monitoring and Compared to the cardiopulmonary exercise testing variables , seeing your similarity and if this first test is applicable to measurement functional capacity in Eisenmenger syndrome

    Time frame: One day

Secondary outcomes

  1. Oxygen uptake kinetics during six minute walk test in Eisenmenger syndrome

    Six minute walk test will be done with metabolic and ventilatory monitoring and we will go evaluate behavior of oxygen uptake kinetics in Eisenmenger Syndrome

    Time frame: one day

  2. Correlation between Functional capacity evaluate with six minute walk test and respiratory function evaluate with manovacuometry, spirometry and muscular respiratory endurance.

    Time frame: one day

  3. Correlation between Functional capacity evaluate with six minute walk test and peripheric muscular function, evaluate with quadriceps dynamometry and strength of handgrip

    Time frame: one day

  4. Correlation between Functional capacity evaluate with six minute walk test and autonomic function, evaluate with cardiofrequency

    Time frame: one day

  5. Correlation between Functional capacity evaluate with six minute walk test and life quality evaluate with SF-36 health survey questionnaire

    Time frame: one day

  6. Correlation between Functional capacity evaluate with six minute walk test and sleep quality, evaluate with pittsburgh questionnaire for sleep and Epworth Sleepiness Scale

    Time frame: one day

  7. Correlation between Functional capacity evaluate with six minute walk test and blood inflammatory mediators and blood lactate

    Time frame: one day

07

Study locations

1 of 1 sites recruiting
  • Universidade Federal de São Paulo
    São Paulo, 04021-001, Brazil
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02752399
Responsible party
Bruna Caroline Matos Garcia (Physiotherapist, Federal University of São Paulo) — Principal investigator
First posted
Apr 27, 2016
Start date
Apr 2016
Primary completion
Dec 2016 (estimated)
Completion
Jun 2017 (estimated)
Last update
Apr 27, 2016

Study contacts

Bruna CM Garcia, principal
Contact
brunacaroline_fisio@hotmail.com
+5512 981254979
Solange Guizilini, mastermind
study chair · Federal University of São Paulo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion